Good morning, everyone. My name is Dina Elmonshed, one of the U.S. biotech analysts here at UBS. And joining me today is the President and CEO of Vertex Pharmaceuticals, Reshma Kewalramani. Thank you ...

Vertex Pharmaceuticals’ third quarter was marked by steady double-digit revenue growth, yet the market responded negatively ...

The market has since validated Guo’s conviction. On Kickstarter, Zettlab raised more than USD 1.4 million, with 80% of ...

One of the most common genetic diseases, AATD, involves the retention of misfolded alpha 1 antitrypsin (AAT) in hepatocytes, ...

(RTTNews) - Vertex Pharmaceuticals Inc. (VRTX) presented new interim data for its investigational therapy povetacicept (pove) in IgA nephropathy (IgAN) and primary membranous nephropathy (pMN) at the ...

With immunology and inflammation blockbusters like AbbVie’s Skyrizi and Rinvoq reeling in nearly $7 billion combined in the ...

Sullivan might be best known for launching the Lumber Liquidators chain. But this week he's raising money for another cause.

We’ve sifted through early Black Friday offers to highlight the best vacuum deals we’ve come across so far, so you can find a high-performing model without the premium price tag. Our favorite upright ...

Tech stocks and top consumer names are increasingly at risk of steep declines in a slowing economy. Click here to see 5 ...

Dezeen Showroom: from wellbeing-enhancing office pods to products that covertly control noise, the following pieces are ...